4-(4-fluorophenoxy)-1-(4-[2-(piperidin-1-yl)ethoxy]phenyl)pyridin-2(1H)-one | 1266775-14-7

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 4-(4-fluorophenoxy)-1-(4-[2-(piperidin-1-yl)ethoxy]phenyl)pyridin-2(1H)-one
• 英文别名: 4-(4-Fluorophenoxy)-1-{4-[2-(piperidin-1-yl)ethoxy]phenyl}pyridin-2(1H)-one；4-(4-fluorophenoxy)-1-[4-(2-piperidin-1-ylethoxy)phenyl]pyridin-2-one
• CAS: 1266775-14-7
• 化学式: C₂₄H₂₅FN₂O₃
• 分子量: 408.473
• InChiKey: HOZLKBNZZMDTTK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.1
• 重原子数：
  30
• 可旋转键数：
  7
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  42
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  4-(叔丁基二甲基硅氧基)苯基硼酸 在 吡啶 、 copper(l) iodide 、 copper diacetate 、 potassium carbonate 、 三苯基膦 、 偶氮二甲酸二乙酯 作用下， 以 四氢呋喃 、 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 65.5h， 生成 4-(4-fluorophenoxy)-1-(4-[2-(piperidin-1-yl)ethoxy]phenyl)pyridin-2(1H)-one
  参考文献：
  名称：

  Discovery of novel phenylpyridone derivatives as potent and selective MCH1R antagonists

  摘要：

  The design, synthesis and structure-activity relationships of a novel class of N-phenylpyridone MCH1R antagonists are described. The core part of the N-phenylpyridone structure was newly designed and the side chain moieties that were attached to the core part were extensively explored. As a result of optimization of the N-phenylpyridone leads, we successfully developed the orally available, and brain-penetrable MCH1R selective antagonist 7c, exhibiting excellent anti-obese effect in diet-induced obese (DIO) mice. (C) 2010 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2010.12.002

文献信息

• Discovery of novel phenylpyridone derivatives as potent and selective MCH1R antagonists
  作者：Yuji Haga、Sayaka Mizutani、Akira Naya、Hiroyuki Kishino、Hisashi Iwaasa、Masahiko Ito、Junko Ito、Minoru Moriya、Nagaaki Sato、Norihiro Takenaga、Akane Ishihara、Shigeru Tokita、Akio Kanatani、Norikazu Ohtake

  DOI：10.1016/j.bmc.2010.12.002

  日期：2011.1

  The design, synthesis and structure-activity relationships of a novel class of N-phenylpyridone MCH1R antagonists are described. The core part of the N-phenylpyridone structure was newly designed and the side chain moieties that were attached to the core part were extensively explored. As a result of optimization of the N-phenylpyridone leads, we successfully developed the orally available, and brain-penetrable MCH1R selective antagonist 7c, exhibiting excellent anti-obese effect in diet-induced obese (DIO) mice. (C) 2010 Elsevier Ltd. All rights reserved.